MIST (Milestone Pharmaceuticals) OCF Yield %: -32.99 (As of Jun. 26, 2026)


MIST Milestone Pharmaceuticals Inc MIST
26 GF Score
Price $1.25
! 6 Warning Signs
View Full Analysis

What is Milestone Pharmaceuticals OCF Yield %?

Milestone Pharmaceuticals MIST -0.40% 26 OCF Yield % is -32.99 as of Jun. 26, 2026. GuruFocus rates MIST with a GF Score™ of 26/100. The stock has 6 warning signs investors should review. Among 1,419 Biotechnology companies, Milestone Pharmaceuticals ranks worse than 77.66% on this metric.

OCF Yield % is calculated as Cash Flow from Operations divided by Market Capitalization. It is a financial solvency ratio that compares the operating cash flow a company is expected to earn against its market value.

As of today, Milestone Pharmaceuticals's Trailing 12-Month Cash Flow from Operations is $-51.14 Mil, and Market Cap is $155.00 Mil. Therefore, Milestone Pharmaceuticals's OCF Yield % for today is -32.99%.

The historical rank and industry rank for Milestone Pharmaceuticals's OCF Yield % or its related term are showing as below:

MIST' s OCF Yield % Range Over the Past 10 Years
Min: -154.97   Med: -36.5   Max: -9.14
Current: -32.99

During the past 9 years, the highest OCF Yield % of Milestone Pharmaceuticals was -9.14%. The lowest was -154.97%. And the median was -36.50%.

MIST's OCF Yield % is ranked worse than
77.66% of 1419 companies
in the Biotechnology industry
Industry Median: -8.48 vs MIST: -32.99

Milestone Pharmaceuticals's OCF Margin % for the quarter that ended in Mar. 2026 was %.

Milestone Pharmaceuticals OCF Yield % Explanation

Similar to Earnings Yield %, OCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high operating cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.

Milestone Pharmaceuticals OCF Yield % Related Terms

Milestone Pharmaceuticals OCF Yield % Historical Data

* Premium members only.

The historical data trend for Milestone Pharmaceuticals's OCF Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Milestone Pharmaceuticals OCF Yield % Chart

Milestone Pharmaceuticals Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
OCF Yield %
Get a 7-Day Free Trial Premium Member Only -16.97 -38.64 -83.02 -22.91 -22.85

Milestone Pharmaceuticals Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
OCF Yield % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -130.46 -48.43 -22.89 -23.81 -45.81

MIST vs TLSA, DTIL, OKUR: OCF Yield % Comparison

For the Biotechnology subindustry, Milestone Pharmaceuticals's OCF Yield %, along with its competitors' market caps and OCF Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Milestone Pharmaceuticals OCF Yield % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Milestone Pharmaceuticals's OCF Yield % distribution charts can be found below:

* The bar in red indicates where Milestone Pharmaceuticals's OCF Yield % falls into.


MIST
26GF Score
Milestone Pharmaceuticals Inc MIST
OCF Yield % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Milestone Pharmaceuticals OCF Yield % Calculation

OCF Yield % is a financial solvency ratio that compares the operating cash flow a company is expected to earn against its market value.

Milestone Pharmaceuticals's OCF Yield % for the fiscal year that ended in Dec. 2025 is calculated as

OCF Yield %=Cash Flow from Operations / Market Cap
=-49.041 / 214.59672
=-22.85%

Milestone Pharmaceuticals's annualized OCF Yield % for the quarter that ended in Mar. 2026 is calculated as

OCF Yield %=Cash Flow from Operations * Annualized Factor / Market Cap
=-16.053 * 4 / 140.17486
=-45.81%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about OCF Yield % →
What does a OCF Yield % of -32.99 mean?
Milestone Pharmaceuticals (MIST) has a OCF Yield % of -32.99 as of Jun. 26, 2026. OCF Yield is calculated as Cash Flow from Operations divided by Market Capitalization. View historical data on Milestone Pharmaceuticals and its competitors. According to the industry distribution chart, Milestone Pharmaceuticals ranks #1102 out of 1419 companies in the Biotechnology industry, placing it in the top 77.7%.
Is Milestone Pharmaceuticals' OCF Yield % too high?
Milestone Pharmaceuticals' current OCF Yield % is -32.99. Based on the distribution chart, Milestone Pharmaceuticals ranks #1102 out of 1419 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, Milestone Pharmaceuticals has a GF Score™ of 26/100, reflecting its overall financial health beyond just this single metric.
How does Milestone Pharmaceuticals' OCF Yield % compare to TLSA and DTIL?
According to the Biotechnology industry distribution chart, Milestone Pharmaceuticals ranks #1102 out of 1419 companies for OCF Yield %. This places Milestone Pharmaceuticals in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Yield % for a Biotechnology company?
A good OCF Yield % depends on the Biotechnology industry context. However, OCF Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Yield % mean?
A high OCF Yield % can signal that a stock is expensive relative to its fundamentals. OCF Yield is calculated as Cash Flow from Operations divided by Market Capitalization. View historical data on Milestone Pharmaceuticals and its competitors. Milestone Pharmaceuticals's current OCF Yield % is -32.99. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Milestone Pharmaceuticals stock overvalued right now?
Milestone Pharmaceuticals (MIST) has a current OCF Yield % of -32.99. The current OCF Yield % is -32.99. Milestone Pharmaceuticals' overall GF Score™ is 26/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Yield % calculated?
OCF Yield % is calculated from a company's financial statements. For Milestone Pharmaceuticals (MIST), the current OCF Yield % is -32.99 as of Jun. 26, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Milestone Pharmaceuticals Business Description

Address 1111 Dr. Frederik-Phillips Boulevard, Suite 420, Montreal, QC, CAN, H4M 2X6
Milestone Pharmaceuticals Inc is a biopharmaceutical company focused on the development and commercialization of cardiovascular medicines. Its approved product CARDAMYST (etripamil) nasal spray is available in the United States and is the self-administered treatment for use by patients anywhere, anytime an attack of PSVT occurs. It operates in single segment.
26GF Score

Get the complete analysis for MIST

OCF Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$1.25
Price